Adverse events in a cohort of HIV infected pregnant and non-pregnant women treated with nevirapine versus non-nevirapine antiretroviral medication.

Adverse events in a cohort of HIV infected pregnant and non-pregnant women treated with nevirapine versus non-nevirapine antiretroviral medication.

BACKGROUND: Predictors of adverse events (AE) associated with nevirapine use are needed to better understand reports of severe rash or liver enzyme elevation (LEE) in HIV+ women. METHODOLOGY: AE rates following ART initiation were retrospectively assessed in a multi-site cohort of 612 women. Predict...

Full description

Bibliographic Details
Main Authors: Erika Aaron, Mirjam-Colette Kempf, Shannon Criniti, Ellen Tedaldi, Ed Gracely, Amy Warriner, Ritu Kumar, Laura H Bachmann
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2935387?pdf=render

Internet

http://europepmc.org/articles/PMC2935387?pdf=render

Similar Items